Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · IEX Real-Time Price · USD
0.632
-0.035 (-5.30%)
At close: Apr 24, 2024, 3:54 PM
0.641
+0.008 (1.33%)
After-hours: Apr 24, 2024, 7:33 PM EDT
Quoin Pharmaceuticals Market Cap
Quoin Pharmaceuticals has a market cap or net worth of $624.02 thousand as of April 24, 2024. Its market cap has decreased by -89.24% in one year.
Market Cap
624.02K
Enterprise Value
-2.21M
1-Year Change
-89.24%
Ranking
Category
Stock Price
$0.63
Market Cap Chart
Since August 1, 2016, Quoin Pharmaceuticals's market cap has decreased from $28.60M to $624.02K, a decrease of -97.82%. That is a compound annual growth rate of -39.03%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 2.40M | - |
Apr 22, 2024 | 2.40M | -7.69% |
Apr 19, 2024 | 2.60M | -3.70% |
Apr 18, 2024 | 2.70M | - |
Apr 17, 2024 | 2.70M | - |
Apr 16, 2024 | 2.70M | 3.85% |
Apr 15, 2024 | 2.60M | -3.70% |
Apr 12, 2024 | 2.70M | -3.57% |
Apr 11, 2024 | 2.80M | -3.45% |
Apr 10, 2024 | 2.90M | - |
Apr 9, 2024 | 2.90M | - |
Apr 8, 2024 | 2.90M | -3.33% |
Apr 5, 2024 | 3.00M | -6.25% |
Apr 4, 2024 | 3.20M | -3.03% |
Apr 3, 2024 | 3.30M | - |
Apr 2, 2024 | 3.30M | -5.71% |
Apr 1, 2024 | 3.50M | - |
Mar 28, 2024 | 3.50M | 9.38% |
Mar 27, 2024 | 3.20M | 3.23% |
Mar 26, 2024 | 3.10M | - |
Mar 25, 2024 | 3.10M | - |
Mar 22, 2024 | 3.10M | -6.06% |
Mar 21, 2024 | 3.30M | - |
Mar 20, 2024 | 3.30M | - |
Mar 19, 2024 | 3.30M | -2.94% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Bluejay Diagnostics | 1.48M |
TC Biopharm (Holdings) | 1.46M |
Galmed Pharmaceuticals | 1.42M |
Bone Biologics | 1.42M |
Akanda | 1.13M |
Allarity Therapeutics | 654.93K |
Aptevo Therapeutics | 489.85K |
Biodexa Pharmaceuticals | 177.86K |